Esperion Therapeutics | ESPR - Sales Revenues

Esperion Therapeutics reported $18.82M in Sales Revenues for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Abbvie ABBV:US USD 15.12B 309M
Amarin AMRN:US USD 89.88M 4.56M
Amgen AMGN:US USD 6.84B 187M
Biogen BIIB:US USD 2.54B 35.5M
Daiichi Sankyo 4568:JP JPY 340.48B 13B
Eli Lilly And LLY:US USD 7.3B 360.2M
Esperion Therapeutics ESPR:US USD 18.82M 162K
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Merk MRK:US USD 13.83B 1.13B
Pfizer PFE:US USD 24.29B 1.65B
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Seattle Genetics SGEN:US USD 528.15M 17.85M